Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 200,221 | 212,869 | 227,800 | 221,083 | 213,365 |
| Cost of Goods | 39,257 | 40,333 | 43,069 | 42,319 | 42,529 |
| Gross Profit | 160,964 | 172,536 | 184,731 | 178,764 | 170,836 |
| Operating Expenses | 145,620 | 155,029 | 160,127 | 154,864 | 153,758 |
| Operating Income | 15,601 | 17,840 | 24,673 | 24,219 | 17,607 |
| Interest Expense | 49 | 51 | 52 | 145 | 43 |
| Other Income | 3,056 | 2,414 | 2,490 | 2,537 | 2,967 |
| Pre-tax Income | 18,608 | 20,203 | 27,111 | 26,611 | 20,531 |
| Income Tax | 8,001 | 9,771 | 10,574 | 9,845 | 9,184 |
| Net Income Continuous | 10,607 | 10,432 | 16,537 | 16,766 | 11,347 |
| Net Income | $10,607 | $10,432 | $16,537 | $16,766 | $11,347 |
| EPS Basic Total Ops | 0.56 | 0.55 | 0.86 | 0.88 | 0.59 |
| EPS Basic Continuous Ops | 0.56 | 0.55 | 0.86 | 0.88 | 0.59 |
| EPS Diluted Total Ops | 0.56 | 0.54 | 0.86 | 0.87 | 0.59 |
| EPS Diluted Continuous Ops | 0.56 | 0.54 | 0.86 | 0.87 | 0.59 |
| EPS Diluted Before Non-Recurring Items | 0.56 | 0.54 | 0.86 | 0.87 | 0.59 |
| EBITDA(a) | $21,160 | $23,542 | $29,757 | $29,090 | $22,766 |